Emergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Since 1998, Emergent has been a go-to source for solving some of the most complex and critical challenges in public health. From initial process and analytical development, to clinical through commercial manufacturing supply, our experienced CDMO team can help guide your project successfully through all stages of the drug development lifecycle.

We can support a wide range of platforms and technologies including, mammalian, microbial, viral, plasma, and advanced therapies to support preclinical through commercial manufacturing. 

Our CDMO capabilities include: 

  • Development Services
  • Drug Substance
  • Drug Product Manufacturing & Packaging/Labeling

Sales Markets

Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)

Meet us at

CPhI North America 2021

Pennsylvania Convention Center, PHL

August 10-12, 2021

Book a meeting
View Our Exhibitor Profile

Meet us at

CPhI Worldwide 2021

Fiera Milano, Milan, Italy

9-11 November 2021

Book a meeting
View Our Exhibitor Profile

Contact information




View All Contact Info

Top Products

Our Resources

Categories affiliated with Emergent BioSolutions Inc.